Form D Explorer

Inspect source fieldsReport a record issue

Form D — ASCENDIA PHARMACEUTICALS, INC.

0001855888-25-000001 · filed Jun 4, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$2,500,000
Reported amount sold
$2,500,000
Minimum investment
$100,000
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
ASCENDIA PHARMACEUTICALS, INC.
CIK
1855888
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
661 US HIGHWAY ONE
NORTH BRUNSWICK, New Jersey 08902
Phone
16099320856

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗